Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 207 entries
Sorted by: Best Match Show Resources per page
Inositol 1,4,5-trisphosphate receptor type 3 is involved in resistance to apoptosis and maintenance of human hepatocellular carcinoma.

Oncology letters

Dos Santos ML, França A, Lima Filho ACM, Florentino RM, Diniz PH, Oliveira Lemos F, Gonçalves CAX, Coelho VL, Lima CX, Foureaux G, Nathanson MH, Vidigal PVT, Leite MF.
PMID: 34966448
Oncol Lett. 2022 Jan;23(1):32. doi: 10.3892/ol.2021.13150. Epub 2021 Nov 25.

The expression of the inositol 1,4,5-trisphosphate receptor type 3 (ITRP3) in hepatocytes is a common event in the pathogenesis of hepatocellular carcinoma (HCC), regardless of the type of underlying liver disease. However, it is not known whether ITPR3 expression...

Cite
Dos Santos ML, França A, Lima Filho ACM, et al. Inositol 1,4,5-trisphosphate receptor type 3 is involved in resistance to apoptosis and maintenance of human hepatocellular carcinoma. Oncol Lett. 2021;23(1):32doi: 10.3892/ol.2021.13150.
Dos Santos, M. L., França, A., Lima Filho, A. C. M., Florentino, R. M., Diniz, P. H., Oliveira Lemos, F., Gonçalves, C. A. X., Coelho, V. L., Lima, C. X., Foureaux, G., Nathanson, M. H., Vidigal, P. V. T., & Leite, M. F. (2022). Inositol 1,4,5-trisphosphate receptor type 3 is involved in resistance to apoptosis and maintenance of human hepatocellular carcinoma. Oncology letters, 23(1), 32. https://doi.org/10.3892/ol.2021.13150
Dos Santos, Marcone Loiola, et al. "Inositol 1,4,5-trisphosphate receptor type 3 is involved in resistance to apoptosis and maintenance of human hepatocellular carcinoma." Oncology letters vol. 23,1 (2022): 32. doi: https://doi.org/10.3892/ol.2021.13150
Dos Santos ML, França A, Lima Filho ACM, Florentino RM, Diniz PH, Oliveira Lemos F, Gonçalves CAX, Coelho VL, Lima CX, Foureaux G, Nathanson MH, Vidigal PVT, Leite MF. Inositol 1,4,5-trisphosphate receptor type 3 is involved in resistance to apoptosis and maintenance of human hepatocellular carcinoma. Oncol Lett. 2022 Jan;23(1):32. doi: 10.3892/ol.2021.13150. Epub 2021 Nov 25. PMID: 34966448; PMCID: PMC8669656.
Copy Download .nbib Format: NLM
"Aerobic glycolytic imaging" of human gliomas using combined pH-, oxygen-, and perfusion-weighted magnetic resonance imaging.

NeuroImage. Clinical

Hagiwara A, Yao J, Raymond C, Cho NS, Everson R, Patel K, Morrow DH, Desousa BR, Mareninov S, Chun S, Nathanson DA, Yong WH, Andrei G, Divakaruni AS, Salamon N, Pope WB, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM.
PMID: 34911188
Neuroimage Clin. 2021;32:102882. doi: 10.1016/j.nicl.2021.102882. Epub 2021 Nov 12.

PURPOSE: To quantify abnormal metabolism of diffuse gliomas using "aerobic glycolytic imaging" and investigate its biological correlation.METHODS: All subjects underwent a pH-weighted amine chemical exchange saturation transfer spin-and-gradient-echo echoplanar imaging (CEST-SAGE-EPI) and dynamic susceptibility contrast perfusion MRI. Relative oxygen...

Cite
Hagiwara A, Yao J, Raymond C, et al. "Aerobic glycolytic imaging" of human gliomas using combined pH-, oxygen-, and perfusion-weighted magnetic resonance imaging. Neuroimage Clin. 2021;32:102882doi: 10.1016/j.nicl.2021.102882.
Hagiwara, A., Yao, J., Raymond, C., Cho, N. S., Everson, R., Patel, K., Morrow, D. H., Desousa, B. R., Mareninov, S., Chun, S., Nathanson, D. A., Yong, W. H., Andrei, G., Divakaruni, A. S., Salamon, N., Pope, W. B., Nghiemphu, P. L., Liau, L. M., Cloughesy, T. F., & Ellingson, B. M. (2021). "Aerobic glycolytic imaging" of human gliomas using combined pH-, oxygen-, and perfusion-weighted magnetic resonance imaging. NeuroImage. Clinical, 32102882. https://doi.org/10.1016/j.nicl.2021.102882
Hagiwara, Akifumi, et al. ""Aerobic glycolytic imaging" of human gliomas using combined pH-, oxygen-, and perfusion-weighted magnetic resonance imaging." NeuroImage. Clinical vol. 32 (2021): 102882. doi: https://doi.org/10.1016/j.nicl.2021.102882
Hagiwara A, Yao J, Raymond C, Cho NS, Everson R, Patel K, Morrow DH, Desousa BR, Mareninov S, Chun S, Nathanson DA, Yong WH, Andrei G, Divakaruni AS, Salamon N, Pope WB, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. "Aerobic glycolytic imaging" of human gliomas using combined pH-, oxygen-, and perfusion-weighted magnetic resonance imaging. Neuroimage Clin. 2021;32:102882. doi: 10.1016/j.nicl.2021.102882. Epub 2021 Nov 12. PMID: 34911188.
Copy Download .nbib Format: NLM
Effect of Playing and Training at Altitude on Concussion Incidence in Professional Football.

Orthopaedic journal of sports medicine

Connolly JG, Nathanson JT, Sobotka S, Haider S, Gometz A, Lovell M, Choudhri T.
PMID: 30560139
Orthop J Sports Med. 2018 Dec 07;6(12):2325967118794928. doi: 10.1177/2325967118794928. eCollection 2018 Dec.

BACKGROUND: Despite the increased attention to sports-related concussion, the literature lacks information about the environmental factors that contribute to concussion incidence. Previous investigators have noted a decreased rate of concussion in football games played at higher altitude.PURPOSE/HYPOTHESIS: The purpose...

Cite
Connolly JG, Nathanson JT, Sobotka S, et al. Effect of Playing and Training at Altitude on Concussion Incidence in Professional Football. Orthop J Sports Med. 2018;6(12):2325967118794928doi: 10.1177/2325967118794928.
Connolly, J. G., Nathanson, J. T., Sobotka, S., Haider, S., Gometz, A., Lovell, M., & Choudhri, T. (2018). Effect of Playing and Training at Altitude on Concussion Incidence in Professional Football. Orthopaedic journal of sports medicine, 6(12), 2325967118794928. https://doi.org/10.1177/2325967118794928
Connolly, James G, et al. "Effect of Playing and Training at Altitude on Concussion Incidence in Professional Football." Orthopaedic journal of sports medicine vol. 6,12 (2018): 2325967118794928. doi: https://doi.org/10.1177/2325967118794928
Connolly JG, Nathanson JT, Sobotka S, Haider S, Gometz A, Lovell M, Choudhri T. Effect of Playing and Training at Altitude on Concussion Incidence in Professional Football. Orthop J Sports Med. 2018 Dec 07;6(12):2325967118794928. doi: 10.1177/2325967118794928. eCollection 2018 Dec. PMID: 30560139; PMCID: PMC6293377.
Copy Download .nbib Format: NLM
Production of Br.

The journal of physical chemistry. A

Sobyra TB, Pliszka H, Bertram TH, Nathanson GM.
PMID: 31251617
J Phys Chem A. 2019 Oct 17;123(41):8942-8953. doi: 10.1021/acs.jpca.9b04225. Epub 2019 Jul 19.

Gas-liquid scattering experiments are used to investigate the oxidation-reduction reaction N

Cite
Sobyra TB, Pliszka H, Bertram TH, et al. Production of Br. J Phys Chem A. 2019;123(41):8942-8953doi: 10.1021/acs.jpca.9b04225.
Sobyra, T. B., Pliszka, H., Bertram, T. H., & Nathanson, G. M. (2019). Production of Br. The journal of physical chemistry. A, 123(41), 8942-8953. https://doi.org/10.1021/acs.jpca.9b04225
Sobyra, Thomas B, et al. "Production of Br." The journal of physical chemistry. A vol. 123,41 (2019): 8942-8953. doi: https://doi.org/10.1021/acs.jpca.9b04225
Sobyra TB, Pliszka H, Bertram TH, Nathanson GM. Production of Br. J Phys Chem A. 2019 Oct 17;123(41):8942-8953. doi: 10.1021/acs.jpca.9b04225. Epub 2019 Jul 19. PMID: 31251617.
Copy Download .nbib Format: NLM
S.

The journal of physical chemistry. A

Karimova NV, Chen J, Gord JR, Staudt S, Bertram TH, Nathanson GM, Gerber RB.
PMID: 31880456
J Phys Chem A. 2020 Jan 30;124(4):711-720. doi: 10.1021/acs.jpca.9b09095. Epub 2020 Jan 22.

Reactions of dinitrogen pentoxide (N

Cite
Karimova NV, Chen J, Gord JR, et al. S. J Phys Chem A. 2020;124(4):711-720doi: 10.1021/acs.jpca.9b09095.
Karimova, N. V., Chen, J., Gord, J. R., Staudt, S., Bertram, T. H., Nathanson, G. M., & Gerber, R. B. (2020). S. The journal of physical chemistry. A, 124(4), 711-720. https://doi.org/10.1021/acs.jpca.9b09095
Karimova, Natalia V, et al. "S." The journal of physical chemistry. A vol. 124,4 (2020): 711-720. doi: https://doi.org/10.1021/acs.jpca.9b09095
Karimova NV, Chen J, Gord JR, Staudt S, Bertram TH, Nathanson GM, Gerber RB. S. J Phys Chem A. 2020 Jan 30;124(4):711-720. doi: 10.1021/acs.jpca.9b09095. Epub 2020 Jan 22. PMID: 31880456.
Copy Download .nbib Format: NLM
Development of a Potent Brain-Penetrant EGFR Tyrosine Kinase Inhibitor against Malignant Brain Tumors.

ACS medicinal chemistry letters

Tsang JE, Urner LM, Kim G, Chow K, Baufeld L, Faull K, Cloughesy TF, Clark PM, Jung ME, Nathanson DA.
PMID: 33062157
ACS Med Chem Lett. 2020 May 01;11(10):1799-1809. doi: 10.1021/acsmedchemlett.9b00599. eCollection 2020 Oct 08.

The epidermal growth factor receptor (EGFR) is genetically altered in nearly 60% of glioblastoma tumors; however, tyrosine kinase inhibitors (TKIs) against EGFR have failed to show efficacy for patients with these lethal brain tumors. This failure is attributed to...

Cite
Tsang JE, Urner LM, Kim G, et al. Development of a Potent Brain-Penetrant EGFR Tyrosine Kinase Inhibitor against Malignant Brain Tumors. ACS Med Chem Lett. 2020;11(10):1799-1809doi: 10.1021/acsmedchemlett.9b00599.
Tsang, J. E., Urner, L. M., Kim, G., Chow, K., Baufeld, L., Faull, K., Cloughesy, T. F., Clark, P. M., Jung, M. E., & Nathanson, D. A. (2020). Development of a Potent Brain-Penetrant EGFR Tyrosine Kinase Inhibitor against Malignant Brain Tumors. ACS medicinal chemistry letters, 11(10), 1799-1809. https://doi.org/10.1021/acsmedchemlett.9b00599
Tsang, Jonathan E, et al. "Development of a Potent Brain-Penetrant EGFR Tyrosine Kinase Inhibitor against Malignant Brain Tumors." ACS medicinal chemistry letters vol. 11,10 (2020): 1799-1809. doi: https://doi.org/10.1021/acsmedchemlett.9b00599
Tsang JE, Urner LM, Kim G, Chow K, Baufeld L, Faull K, Cloughesy TF, Clark PM, Jung ME, Nathanson DA. Development of a Potent Brain-Penetrant EGFR Tyrosine Kinase Inhibitor against Malignant Brain Tumors. ACS Med Chem Lett. 2020 May 01;11(10):1799-1809. doi: 10.1021/acsmedchemlett.9b00599. eCollection 2020 Oct 08. PMID: 33062157; PMCID: PMC7549123.
Copy Download .nbib Format: NLM
Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Yadav S, Hu C, Nathanson KL, Weitzel JN, Goldgar DE, Kraft P, Gnanaolivu RD, Na J, Huang H, Boddicker NJ, Larson N, Gao C, Yao S, Weinberg C, Vachon CM, Trentham-Dietz A, Taylor JA, Sandler DR, Patel A, Palmer JR, Olson JE, Neuhausen S, Martinez E, Lindstrom S, Lacey JV, Kurian AW, John EM, Haiman C, Bernstein L, Auer PW, Anton-Culver H, Ambrosone CB, Karam R, Chao E, Yussuf A, Pesaran T, Dolinsky JS, Hart SN, LaDuca H, Polley EC, Domchek SM, Couch FJ.
PMID: 34672684
J Clin Oncol. 2021 Dec 10;39(35):3918-3926. doi: 10.1200/JCO.21.00640. Epub 2021 Oct 21.

PURPOSE: To determine the contribution of germline pathogenic variants (PVs) in hereditary cancer testing panel genes to invasive lobular carcinoma (ILC) of the breast.MATERIALS AND METHODS: The study included 2,999 women with ILC from a population-based cohort and 3,796...

Cite
Yadav S, Hu C, Nathanson KL, et al. Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast. J Clin Oncol. 2021;39(35):3918-3926doi: 10.1200/JCO.21.00640.
Yadav, S., Hu, C., Nathanson, K. L., Weitzel, J. N., Goldgar, D. E., Kraft, P., Gnanaolivu, R. D., Na, J., Huang, H., Boddicker, N. J., Larson, N., Gao, C., Yao, S., Weinberg, C., Vachon, C. M., Trentham-Dietz, A., Taylor, J. A., Sandler, D. R., Patel, A., Palmer, J. R., Olson, J. E., Neuhausen, S., Martinez, E., Lindstrom, S., Lacey, J. V., Kurian, A. W., John, E. M., Haiman, C., Bernstein, L., Auer, P. W., Anton-Culver, H., Ambrosone, C. B., Karam, R., Chao, E., Yussuf, A., Pesaran, T., Dolinsky, J. S., Hart, S. N., LaDuca, H., Polley, E. C., Domchek, S. M., & Couch, F. J. (2021). Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 39(35), 3918-3926. https://doi.org/10.1200/JCO.21.00640
Yadav, Siddhartha, et al. "Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 39,35 (2021): 3918-3926. doi: https://doi.org/10.1200/JCO.21.00640
Yadav S, Hu C, Nathanson KL, Weitzel JN, Goldgar DE, Kraft P, Gnanaolivu RD, Na J, Huang H, Boddicker NJ, Larson N, Gao C, Yao S, Weinberg C, Vachon CM, Trentham-Dietz A, Taylor JA, Sandler DR, Patel A, Palmer JR, Olson JE, Neuhausen S, Martinez E, Lindstrom S, Lacey JV, Kurian AW, John EM, Haiman C, Bernstein L, Auer PW, Anton-Culver H, Ambrosone CB, Karam R, Chao E, Yussuf A, Pesaran T, Dolinsky JS, Hart SN, LaDuca H, Polley EC, Domchek SM, Couch FJ. Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast. J Clin Oncol. 2021 Dec 10;39(35):3918-3926. doi: 10.1200/JCO.21.00640. Epub 2021 Oct 21. PMID: 34672684; PMCID: PMC8660003.
Copy Download .nbib Format: NLM
A common language for Gulf War Illness (GWI) research studies: GWI common data elements.

Life sciences

Cohen DE, Sullivan KA, McNeil RB, Klimas NG, McNeil R, Ashford W, Bested A, Bunker J, Cheema A, Cohen D, Cook D, Cournoyer J, Craddock T, Golier J, Hardie A, Helmer D, Lindheimer JB, Lloyd PJ, Kerr K, Krengel M, Nadkarni S, Nugent S, Paris B, Reinhard M, Rumm P, Schneiderman A, Sims KJ, Steele L, Turner M, Sullivan K, Abdullah L, Abreu M, Abu-Donia M, Aenlle K, Arocho J, Balbin E, Baraniuk J, Block K, Block M, DeBeer B, Engdahl B, Filipov N, Fletcher MA, Kalasinsky V, Kokkotou E, Lidie K, Little D, Loging W, Morris M, Nathanson L, Nichols MD, Pasinetti G, Shungu D, Waziry P, VanLeeuwen J, Younger J, Klimas N.
PMID: 34352259
Life Sci. 2021 Aug 02;119818. doi: 10.1016/j.lfs.2021.119818. Epub 2021 Aug 02.

AIMS: The Gulf War Illness programs (GWI) of the United States Department of Veteran Affairs and the Department of Defense Congressionally Directed Medical Research Program collaborated with experts to develop Common Data Elements (CDEs) to standardize and systematically collect,...

Cite
Cohen DE, Sullivan KA, McNeil RB, et al. A common language for Gulf War Illness (GWI) research studies: GWI common data elements. Life Sci. 2021;119818doi: 10.1016/j.lfs.2021.119818.
Cohen, D. E., Sullivan, K. A., McNeil, R. B., Klimas, N. G., McNeil, R., Ashford, W., Bested, A., Bunker, J., Cheema, A., Cohen, D., Cook, D., Cournoyer, J., Craddock, T., Golier, J., Hardie, A., Helmer, D., Lindheimer, J. B., Lloyd, P. J., Kerr, K., Krengel, M., Nadkarni, S., Nugent, S., Paris, B., Reinhard, M., Rumm, P., Schneiderman, A., Sims, K. J., Steele, L., Turner, M., Sullivan, K., Abdullah, L., Abreu, M., Abu-Donia, M., Aenlle, K., Arocho, J., Balbin, E., Baraniuk, J., Block, K., Block, M., DeBeer, B., Engdahl, B., Filipov, N., Fletcher, M. A., Kalasinsky, V., Kokkotou, E., Lidie, K., Little, D., Loging, W., Morris, M., Nathanson, L., Nichols, M. D., Pasinetti, G., Shungu, D., Waziry, P., VanLeeuwen, J., Younger, J., & Klimas, N. (2021). A common language for Gulf War Illness (GWI) research studies: GWI common data elements. Life sciences, 119818. https://doi.org/10.1016/j.lfs.2021.119818
Cohen, Devra E, et al. "A common language for Gulf War Illness (GWI) research studies: GWI common data elements." Life sciences vol. (2021): 119818. doi: https://doi.org/10.1016/j.lfs.2021.119818
Cohen DE, Sullivan KA, McNeil RB, Klimas NG, McNeil R, Ashford W, Bested A, Bunker J, Cheema A, Cohen D, Cook D, Cournoyer J, Craddock T, Golier J, Hardie A, Helmer D, Lindheimer JB, Lloyd PJ, Kerr K, Krengel M, Nadkarni S, Nugent S, Paris B, Reinhard M, Rumm P, Schneiderman A, Sims KJ, Steele L, Turner M, Sullivan K, Abdullah L, Abreu M, Abu-Donia M, Aenlle K, Arocho J, Balbin E, Baraniuk J, Block K, Block M, DeBeer B, Engdahl B, Filipov N, Fletcher MA, Kalasinsky V, Kokkotou E, Lidie K, Little D, Loging W, Morris M, Nathanson L, Nichols MD, Pasinetti G, Shungu D, Waziry P, VanLeeuwen J, Younger J, Klimas N. A common language for Gulf War Illness (GWI) research studies: GWI common data elements. Life Sci. 2021 Aug 02;119818. doi: 10.1016/j.lfs.2021.119818. Epub 2021 Aug 02. PMID: 34352259.
Copy Download .nbib Format: NLM
From Race-Based to Precision Oncology: Leveraging Behavioral Economics and the Electronic Health Record to Advance Health Equity in Cancer Care.

JCO precision oncology

Lau-Min KS, Guerra CE, Nathanson KL, Bekelman JE.
PMID: 34250405
JCO Precis Oncol. 2021 Feb 17;5. doi: 10.1200/PO.20.00418. eCollection 2021.

No abstract available.

Cite
Lau-Min KS, Guerra CE, Nathanson KL, et al. From Race-Based to Precision Oncology: Leveraging Behavioral Economics and the Electronic Health Record to Advance Health Equity in Cancer Care. JCO Precis Oncol. 2021;5doi: 10.1200/PO.20.00418.
Lau-Min, K. S., Guerra, C. E., Nathanson, K. L., & Bekelman, J. E. (2021). From Race-Based to Precision Oncology: Leveraging Behavioral Economics and the Electronic Health Record to Advance Health Equity in Cancer Care. JCO precision oncology, 5. https://doi.org/10.1200/PO.20.00418
Lau-Min, Kelsey S, et al. "From Race-Based to Precision Oncology: Leveraging Behavioral Economics and the Electronic Health Record to Advance Health Equity in Cancer Care." JCO precision oncology vol. 5 (2021). doi: https://doi.org/10.1200/PO.20.00418
Lau-Min KS, Guerra CE, Nathanson KL, Bekelman JE. From Race-Based to Precision Oncology: Leveraging Behavioral Economics and the Electronic Health Record to Advance Health Equity in Cancer Care. JCO Precis Oncol. 2021 Feb 17;5. doi: 10.1200/PO.20.00418. eCollection 2021. PMID: 34250405; PMCID: PMC8232564.
Copy Download .nbib Format: NLM
Multigene Panel Testing in Individuals With Hepatocellular Carcinoma Identifies Pathogenic Germline Variants.

JCO precision oncology

Mezina A, Philips N, Bogus Z, Erez N, Xiao R, Fan R, Olthoff KM, Reddy KR, Samadder NJ, Nielsen SM, Hatchell KE, Esplin ED, Rustgi AK, Katona BW, Hoteit MA, Nathanson KL, Wangensteen KJ.
PMID: 34250406
JCO Precis Oncol. 2021 Jun 10;5. doi: 10.1200/PO.21.00079. eCollection 2021.

Hepatocellular carcinoma (HCC) has well-defined environmental risk factors. In addition, epidemiologic studies have suggested hereditary risk factors. The goals of this study were to determine the rate of pathogenic and likely pathogenic (P/LP) germline variants in cancer predisposition genes...

Cite
Mezina A, Philips N, Bogus Z, et al. Multigene Panel Testing in Individuals With Hepatocellular Carcinoma Identifies Pathogenic Germline Variants. JCO Precis Oncol. 2021;5doi: 10.1200/PO.21.00079.
Mezina, A., Philips, N., Bogus, Z., Erez, N., Xiao, R., Fan, R., Olthoff, K. M., Reddy, K. R., Samadder, N. J., Nielsen, S. M., Hatchell, K. E., Esplin, E. D., Rustgi, A. K., Katona, B. W., Hoteit, M. A., Nathanson, K. L., & Wangensteen, K. J. (2021). Multigene Panel Testing in Individuals With Hepatocellular Carcinoma Identifies Pathogenic Germline Variants. JCO precision oncology, 5. https://doi.org/10.1200/PO.21.00079
Mezina, Anya, et al. "Multigene Panel Testing in Individuals With Hepatocellular Carcinoma Identifies Pathogenic Germline Variants." JCO precision oncology vol. 5 (2021). doi: https://doi.org/10.1200/PO.21.00079
Mezina A, Philips N, Bogus Z, Erez N, Xiao R, Fan R, Olthoff KM, Reddy KR, Samadder NJ, Nielsen SM, Hatchell KE, Esplin ED, Rustgi AK, Katona BW, Hoteit MA, Nathanson KL, Wangensteen KJ. Multigene Panel Testing in Individuals With Hepatocellular Carcinoma Identifies Pathogenic Germline Variants. JCO Precis Oncol. 2021 Jun 10;5. doi: 10.1200/PO.21.00079. eCollection 2021. PMID: 34250406; PMCID: PMC8232566.
Copy Download .nbib Format: NLM
Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers.

European journal of human genetics : EJHG

Walker LC, Marquart L, Pearson JF, Wiggins GAR, O'Mara TA, Parsons MT, Barrowdale D, McGuffog L, Dennis J, Benitez J, Slavin TP, Radice P, Frost D, Godwin AK, Meindl A, Schmutzler RK, Isaacs C, Peshkin BN, Caldes T, Hogervorst FBL, Lazaro C, Jakubowska A, Montagna M, Chen X, Offit K, Hulick PJ, Andrulis IL, Lindblom A, Nussbaum RL, Nathanson KL, Chenevix-Trench G, Antoniou AC, Couch FJ, Spurdle AB.
PMID: 30135485
Eur J Hum Genet. 2019 Jan;27(1):167-168. doi: 10.1038/s41431-018-0216-1.

This Article was originally published under a CC BY-NC-SA 4.0 license, but has now been made available under a CC BY 4.0 license. The PDF and HTML versions of the Article have been modified accordingly.

Cite
Walker LC, Marquart L, Pearson JF, et al. Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers. Eur J Hum Genet. 2019;27(1):167-168doi: 10.1038/s41431-018-0216-1.
Walker, L. C., Marquart, L., Pearson, J. F., Wiggins, G. A. R., O'Mara, T. A., Parsons, M. T., Barrowdale, D., McGuffog, L., Dennis, J., Benitez, J., Slavin, T. P., Radice, P., Frost, D., Godwin, A. K., Meindl, A., Schmutzler, R. K., Isaacs, C., Peshkin, B. N., Caldes, T., Hogervorst, F. B. L., Lazaro, C., Jakubowska, A., Montagna, M., Chen, X., Offit, K., Hulick, P. J., Andrulis, I. L., Lindblom, A., Nussbaum, R. L., Nathanson, K. L., Chenevix-Trench, G., Antoniou, A. C., Couch, F. J., & Spurdle, A. B. (2019). Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers. European journal of human genetics : EJHG, 27(1), 167-168. https://doi.org/10.1038/s41431-018-0216-1
Walker, Logan C, et al. "Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers." European journal of human genetics : EJHG vol. 27,1 (2019): 167-168. doi: https://doi.org/10.1038/s41431-018-0216-1
Walker LC, Marquart L, Pearson JF, Wiggins GAR, O'Mara TA, Parsons MT, Barrowdale D, McGuffog L, Dennis J, Benitez J, Slavin TP, Radice P, Frost D, Godwin AK, Meindl A, Schmutzler RK, Isaacs C, Peshkin BN, Caldes T, Hogervorst FBL, Lazaro C, Jakubowska A, Montagna M, Chen X, Offit K, Hulick PJ, Andrulis IL, Lindblom A, Nussbaum RL, Nathanson KL, Chenevix-Trench G, Antoniou AC, Couch FJ, Spurdle AB. Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers. Eur J Hum Genet. 2019 Jan;27(1):167-168. doi: 10.1038/s41431-018-0216-1. PMID: 30135485; PMCID: PMC6303246.
Copy Download .nbib Format: NLM
Molecular Mechanism for Protection Against Liver Failure in Human Yellow Fever Infection.

Hepatology communications

Lemos FO, França A, Lima Filho ACM, Florentino RM, Santos ML, Missiaggia DG, Rodrigues GOL, Dias FF, Souza Passos IB, Teixeira MM, Andrade AMF, Lima CX, Vidigal PVT, Costa VV, Fonseca MC, Nathanson MH, Leite MF.
PMID: 32363317
Hepatol Commun. 2020 Mar 16;4(5):657-669. doi: 10.1002/hep4.1504. eCollection 2020 May.

Yellow fever (YF) is a viral hemorrhagic fever that typically involves the liver. Brazil recently experienced its largest recorded YF outbreak, and the disease was fatal in more than a third of affected individuals, mostly because of acute liver...

Cite
Lemos FO, França A, Lima Filho ACM, et al. Molecular Mechanism for Protection Against Liver Failure in Human Yellow Fever Infection. Hepatol Commun. 2020;4(5):657-669doi: 10.1002/hep4.1504.
Lemos, F. O., França, A., Lima Filho, A. C. M., Florentino, R. M., Santos, M. L., Missiaggia, D. G., Rodrigues, G. O. L., Dias, F. F., Souza Passos, I. B., Teixeira, M. M., Andrade, A. M. F., Lima, C. X., Vidigal, P. V. T., Costa, V. V., Fonseca, M. C., Nathanson, M. H., & Leite, M. F. (2020). Molecular Mechanism for Protection Against Liver Failure in Human Yellow Fever Infection. Hepatology communications, 4(5), 657-669. https://doi.org/10.1002/hep4.1504
Lemos, Fernanda de Oliveira, et al. "Molecular Mechanism for Protection Against Liver Failure in Human Yellow Fever Infection." Hepatology communications vol. 4,5 (2020): 657-669. doi: https://doi.org/10.1002/hep4.1504
Lemos FO, França A, Lima Filho ACM, Florentino RM, Santos ML, Missiaggia DG, Rodrigues GOL, Dias FF, Souza Passos IB, Teixeira MM, Andrade AMF, Lima CX, Vidigal PVT, Costa VV, Fonseca MC, Nathanson MH, Leite MF. Molecular Mechanism for Protection Against Liver Failure in Human Yellow Fever Infection. Hepatol Commun. 2020 Mar 16;4(5):657-669. doi: 10.1002/hep4.1504. eCollection 2020 May. PMID: 32363317; PMCID: PMC7193135.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 207 entries